How to Determine Unresectability in Hilar Cholangiocarcinoma

Surg Clin North Am. 2024 Feb;104(1):197-214. doi: 10.1016/j.suc.2023.09.001. Epub 2023 Sep 27.

Abstract

Hilar cholangiocarcinoma is considered a biologically aggressive disease for which surgical resection remains the only curative treatment. Preoperative evaluation for resectability is challenging given tumor proximity to the porta hepatis, but minimal benefit and increased morbidity precludes recommendation for margin positive resection. This article reviews the determination of unresectability in hilar cholangiocarcinoma through discussion of the preoperative assessment, the intraoperative assessment, and key steps of surgical resection, as well as treatment options for unresectable tumors. Overall, evaluating patients preoperatively for resectability requires a multidisciplinary, holistic, and individualized approach to accurately determine resectability and optimize clinical outcomes for patients with hilar cholangiocarcinoma.

Keywords: Hilar cholangiocarcinoma; Klatskin tumor; Resectability; Transplant; Unresectability; Vascular invasion.

Publication types

  • Review

MeSH terms

  • Bile Duct Neoplasms* / pathology
  • Bile Duct Neoplasms* / surgery
  • Bile Ducts, Intrahepatic / pathology
  • Cholangiocarcinoma* / pathology
  • Cholangiocarcinoma* / surgery
  • Hepatectomy
  • Humans
  • Klatskin Tumor* / surgery